PharmaSource: The External Manufacturing Community

Days

Hours

Minutes

Seconds

Your Biopharma Outsourcing Intelligence Hub

Trusted by 50,000+ biopharma manufacturing professionals Sign up for Newsletter

NAMSA and Lexitas Form Strategic CRO Partnership for Ophthalmic Medical Device Development

Charles River Laboratories Expands GEMS Offering with Rat IVF Service

Emergent BioSolutions Signs $34.5 Million Agreement with Substipharm for JE Vaccine Manufacturing

CDMO Compliance Audits Miss the Risks That Cause Supply Failures

Emergent BioSolutions Signs $50 Million Manufacturing Agreement with SAB Biotherapeutics

Parexel Strengthens CRO Pharmacovigilance Offering Through Vitrana Deal

LTS Lohmann Expands CDMO Services to Ophthalmic Drug Delivery in U.S.

Mikart Opens New Atlanta Headquarters

PharmaLogic Opens PET Radiopharmaceutical Facility in Atlanta

Genezen Partners with Gray Foundation to Advance CLN6 Gene Therapy to Phase 1/2

DINAMIQS Secures Swissmedic License for Viral Vector cGMP Manufacturing

Charles River Laboratories Expands GEMS Offering with Rat IVF Service

Emergent BioSolutions Signs $34.5 Million Agreement with Substipharm for JE Vaccine Manufacturing

CDMO Compliance Audits Miss the Risks That Cause Supply Failures

PODCASTS

How to Manage Molecule Uncertainty: Nick Wigdahl on Portfolio Optimization and Pharma Lifecycle Strategy

IPSC Manufacturing: The 30-Year Journey From Dolly the Sheep to Clinical-Grade Cell Therapies

SPOTLIGHT

Why Compliance-Driven CDMOs Win Sponsor Contracts

RESOURCES

CDMO Contract Negotiations Timelines Explained

Target Product Profile (TPP) Explained

Why Compliance-Driven CDMOs Win Sponsor Contracts

UPCOMING EVENTS

PharmaSource: The External Manufacturing Community

NAMSA and Lexitas Form Strategic CRO Partnership for Ophthalmic Medical Device Development

NAMSA and Lexitas Form Strategic CRO Partnership for Ophthalmic Medical Device Development

Charles River Laboratories Expands GEMS Offering with Rat IVF Service

Emergent BioSolutions Signs $34.5 Million Agreement with Substipharm for JE Vaccine Manufacturing

CDMO Compliance Audits Miss the Risks That Cause Supply Failures

Emergent BioSolutions Signs $50 Million Manufacturing Agreement with SAB Biotherapeutics

Parexel Strengthens CRO Pharmacovigilance Offering Through Vitrana Deal

LTS Lohmann Expands CDMO Services to Ophthalmic Drug Delivery in U.S.

Mikart Opens New Atlanta Headquarters

PharmaLogic Opens PET Radiopharmaceutical Facility in Atlanta

Genezen Partners with Gray Foundation to Advance CLN6 Gene Therapy to Phase 1/2

DINAMIQS Secures Swissmedic License for Viral Vector cGMP Manufacturing

Charles River Laboratories Expands GEMS Offering with Rat IVF Service

Emergent BioSolutions Signs $34.5 Million Agreement with Substipharm for JE Vaccine Manufacturing

CDMO Compliance Audits Miss the Risks That Cause Supply Failures

How to Manage Molecule Uncertainty: Nick Wigdahl on Portfolio Optimization and Pharma Lifecycle Strategy

IPSC Manufacturing: The 30-Year Journey From Dolly the Sheep to Clinical-Grade Cell Therapies

Why Compliance-Driven CDMOs Win Sponsor Contracts

CDMO Contract Negotiations Timelines Explained

Target Product Profile (TPP) Explained

Why Compliance-Driven CDMOs Win Sponsor Contracts

CDMO Live Europe 2026

External Manufacturing Leaders Rotterdam 2026

CDMO Live Americas 2026

External Manufacturing Leaders Boston 2026

Welcome to PharmaSource

Follow us

Top Links

Get in touch